Search research articles
Contact Us
Filters
Showing results (221-230 of 250) with videos related to
Page
of 25
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 1, 2016
The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma
Valerie W Rusch, Kari Chansky, Hedy L Kindler, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 3, 2008
Single-agent pemetrexed for chemonaïve and pretreated patients with malignant pleural mesothelioma: results of an International Expanded Access Program
Paul Taylor, Bruno Castagneto, Graham Dark, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 2, 2013
A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer
Luis Paz-Ares, Beatrix Bálint, Richard H de Boer, et al.
Journal of the National Cancer Institute
|
March 22, 2007
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer
Jan P van Meerbeeck, Gijs W P M Kramer, Paul E Y Van Schil, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 7, 2002
Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy
Suresh Senan, Sjaak Burgers, Michael J Samson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 21, 2019
Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study
Dean A Fennell, Paul Baas, Paul Taylor, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 26, 2010
Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studies
V Surmont, E F Smit, M de Jonge, et al.
The European Respiratory Journal
|
June 6, 2024
A randomised phase II study of extended pleurectomy/decortication preceded or followed by chemotherapy in patients with early-stage pleural mesothelioma: EORTC 1205
Jo Raskin, Veerle Surmont, Alexander P W M Maat, et al.
Molecular Oncology
|
December 1, 2022
Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition
Sabine Paternot, Eric Raspé, Clément Meiller, et al.
Cancer Treatment Reviews
|
June 24, 2014
Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors
Christian Rolfo, Elisa Giovannetti, David S Hong, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 250) with videos related to
Sort By:
Page
of 25
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 1, 2016
The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma
Valerie W Rusch, Kari Chansky, Hedy L Kindler, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 3, 2008
Single-agent pemetrexed for chemonaïve and pretreated patients with malignant pleural mesothelioma: results of an International Expanded Access Program
Paul Taylor, Bruno Castagneto, Graham Dark, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 2, 2013
A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer
Luis Paz-Ares, Beatrix Bálint, Richard H de Boer, et al.
Journal of the National Cancer Institute
|
March 22, 2007
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer
Jan P van Meerbeeck, Gijs W P M Kramer, Paul E Y Van Schil, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 7, 2002
Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy
Suresh Senan, Sjaak Burgers, Michael J Samson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 21, 2019
Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study
Dean A Fennell, Paul Baas, Paul Taylor, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 26, 2010
Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studies
V Surmont, E F Smit, M de Jonge, et al.
The European Respiratory Journal
|
June 6, 2024
A randomised phase II study of extended pleurectomy/decortication preceded or followed by chemotherapy in patients with early-stage pleural mesothelioma: EORTC 1205
Jo Raskin, Veerle Surmont, Alexander P W M Maat, et al.
Molecular Oncology
|
December 1, 2022
Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition
Sabine Paternot, Eric Raspé, Clément Meiller, et al.
Cancer Treatment Reviews
|
June 24, 2014
Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors
Christian Rolfo, Elisa Giovannetti, David S Hong, et al.
Page
of 25